{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:58:31Z","timestamp":1791050311011,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470594"],"award-info":[{"award-number":["81470594"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ymthe.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T05:06:06Z","timestamp":1614402366000},"page":"2268-2280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting choroidal vascular dysfunction via inhibition of circRNA-FoxO1 for prevention and management of myopic pathology"],"prefix":"10.1016","volume":"29","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Shan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-6413","authenticated-orcid":false,"given":"Biao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2021.02.025_bib1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2021.02.025_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jama.2020.10953","article-title":"Reducing the progression of myopia","volume":"324","author":"Bressler","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2021.02.025_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2017.09.004","article-title":"The epidemics of myopia: aetiology and prevention","volume":"62","author":"Morgan","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib4","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.nano.2017.05.001","article-title":"Ion-paired pirenzepine-loaded micelles as an ophthalmic delivery system for the treatment of myopia","volume":"13","author":"Li","year":"2017","journal-title":"Nanomedicine (Lond.)"},{"issue":"6","key":"10.1016\/j.ymthe.2021.02.025_bib5","first-page":"CD007679","article-title":"Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia","author":"Barsam","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2021.02.025_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ophtha.2014.07.042","article-title":"Influence of ocular wavefront aberrations on axial length elongation in myopic children treated with overnight orthokeratology","volume":"122","author":"Hiraoka","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2021.02.025_bib7","doi-asserted-by":"crossref","first-page":"e1003299","DOI":"10.1371\/journal.pgen.1003299","article-title":"Genome-wide analysis points to roles for extracellular matrix remodeling, the visual cycle, and neuronal development in myopia","volume":"9","author":"Kiefer","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ymthe.2021.02.025_bib8","doi-asserted-by":"crossref","first-page":"e200567","DOI":"10.1001\/jamanetworkopen.2020.0567","article-title":"Prevalence of myopic maculopathy among adults in a Russian population","volume":"3","author":"Bikbov","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ymthe.2021.02.025_bib9","doi-asserted-by":"crossref","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control","volume":"115","author":"Wu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2021.02.025_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2014.02.001","article-title":"Functional and morphological characteristics of the retinal and choroidal vasculature","volume":"40","author":"Yu","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib11","first-page":"CD011160","article-title":"Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia","volume":"12","author":"Zhu","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ymthe.2021.02.025_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/ars.2017.7275","article-title":"Hypoxia and redox signaling on extracellular matrix remodeling: from mechanisms to pathological implications","volume":"27","author":"Labrousse-Arias","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ymthe.2021.02.025_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","article-title":"The biogenesis, biology and characterization of circular RNAs","volume":"20","author":"Kristensen","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2021.02.025_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrm.2015.32","article-title":"The biogenesis and emerging roles of circular RNAs","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2021.02.025_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","article-title":"The biogenesis, functions, and challenges of circular RNAs","volume":"71","author":"Li","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2021.02.025_bib16","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41593-019-0501-5","article-title":"An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations","volume":"22","author":"Dube","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2021.02.025_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41569-019-0185-2","article-title":"Circular RNAs open a new chapter in cardiovascular biology","volume":"16","author":"Aufiero","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ymthe.2021.02.025_bib18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","article-title":"The landscape of circular RNA in cancer","volume":"176","author":"Vo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2021.02.025_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.preteyeres.2009.12.002","article-title":"The multifunctional choroid","volume":"29","author":"Nickla","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00417-018-4012-y","article-title":"Vessel density, retinal thickness, and choriocapillaris vascular flow in myopic eyes on OCT angiography","volume":"256","author":"Milani","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ymthe.2021.02.025_bib21","doi-asserted-by":"crossref","first-page":"102878","DOI":"10.1016\/j.ebiom.2020.102878","article-title":"Scleral HIF-1\u03b1 is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesis","volume":"57","author":"Zhao","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2021.02.025_bib22","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1167\/iovs.17-23580","article-title":"The role of the RhoA\/ROCK signaling pathway in mechanical strain-Induced scleral myofibroblast differentiation","volume":"59","author":"Yuan","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2021.02.025_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2021.02.025_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2013.03.008","article-title":"The choroid as a sclera growth regulator","volume":"114","author":"Summers","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/bs.pmbts.2015.06.014","article-title":"RPE and choroid mechanisms underlying ocular growth and myopia","volume":"134","author":"Zhang","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ymthe.2021.02.025_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","article-title":"OCT angiography and evaluation of the choroid and choroidal vascular disorders","volume":"67","author":"Borrelli","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib27","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1167\/iovs.15-16446","article-title":"Longitudinal changes in choroidal thickness and eye growth in childhood","volume":"56","author":"Read","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2021.02.025_bib28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.ophtha.2013.02.005","article-title":"Choroidal thickness measurement in myopic eyes by enhanced depth optical coherence tomography","volume":"120","author":"Ho","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2021.02.025_bib29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.preteyeres.2012.04.001","article-title":"Choroidal neovascularization in pathological myopia","volume":"31","author":"Neelam","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2017.10.001","article-title":"Development of the hyaloid, choroidal and retinal vasculatures in the fetal human eye","volume":"62","author":"Lutty","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ymthe.2021.02.025_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10456-020-09740-y","article-title":"IQGAP1 causes choroidal neovascularization by sustaining VEGFR2-mediated Rac1 activation","volume":"23","author":"Wang","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ymthe.2021.02.025_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41580-019-0146-y","article-title":"The innate function of circular RNAs","volume":"20","author":"Zlotorynski","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2021.02.025_bib33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ymthe.2021.02.025_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2014.10.005","article-title":"Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye","volume":"21","author":"Sene","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2021.02.025_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001621001283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:01:18Z","timestamp":1761501678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001621001283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1525001621001283"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting choroidal vascular dysfunction via inhibition of circRNA-FoxO1 for prevention and management of myopic pathology","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}